🇺🇸 CVP in United States

FDA authorised CVP on 10 December 1992

Marketing authorisations

FDA — authorised 10 December 1992

  • Application: ANDA074091
  • Marketing authorisation holder: OHM LABS
  • Status: supplemented

FDA — authorised 12 April 1993

  • Application: NDA019658
  • Marketing authorisation holder: BAYER HEALTHCARE LLC
  • Status: supplemented

FDA — authorised 14 January 1998

  • Application: NDA020802
  • Marketing authorisation holder: HALEON US HOLDINGS
  • Status: supplemented

FDA — authorised 21 June 2005

  • Application: ANDA077349
  • Marketing authorisation holder: PERRIGO R AND D
  • Status: supplemented

FDA — authorised 21 December 2005

  • Application: NDA021394
  • Marketing authorisation holder: HALEON US HOLDINGS
  • Status: supplemented

Other Oncology approved in United States

Frequently asked questions

Is CVP approved in United States?

Yes. FDA authorised it on 10 December 1992; FDA authorised it on 12 April 1993; FDA authorised it on 14 January 1998.

Who is the marketing authorisation holder for CVP in United States?

OHM LABS holds the US marketing authorisation.